Revance Therapeutics Inc. (RVNC)
Delisted
6 Feb 2025
NASDAQ (NMS) NASDAQ (NMS) Primary $
3. 65
0
0%
$
393.94M Market Cap
- P/E Ratio
- Div Yield
0 Volume
-2.3 Eps
$ 3.65
Previous Close Investors:
Day Range
0 0
Year Range
0 7.56
Want to track RVNC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Revance Therapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| KLM Kevin L. Mccreless CONCOURSE FINANCIAL GROUP SECURITIES Inc. | 570 | $2.8 | - | -$2.8 | -100% |
 Guillaume Binnendijk Cigogne Management SA | 111,825 | $339,948 | $339,948 | - | - |
